Listed

Champions Oncology, Inc.

CSBRNasdaqCIK 771856HealthcareFiscal year ends Apr 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$15.2m, Q1 FY2027
Operating income−$409.0k, Q1 FY2027
Net income−$426.0k, Q1 FY2027
Champions Oncology, Inc., income statement, quarterly
Line itemUnitQ2 FY20242023-10-31Q3 FY20242024-01-31Q4 FY20242024-04-30Q1 FY20252024-07-31Q2 FY20252024-10-31Q3 FY20252025-01-31Q4 FY20252025-04-30Q1 FY20262025-07-31Q2 FY20262025-10-31Q3 FY20262026-01-31Q4 FY20262026-04-30Q1 FY20272026-07-31
Revenue$m11.6Revenue, Q2 FY2024, three months to 2023-10-31$11.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure12.0Revenue, Q3 FY2024, three months to 2024-01-31$12.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure14.0Revenue, Q4 FY2024, three months to 2024-04-30$14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure14.1Revenue, Q1 FY2025, three months to 2024-07-31$14.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure13.5Revenue, Q2 FY2025, three months to 2024-10-31$13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure17.0Revenue, Q3 FY2025, three months to 2025-01-31$17.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure12.4Revenue, Q4 FY2025, three months to 2025-04-30$12.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure14.0Revenue, Q1 FY2026, three months to 2025-07-31$14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure15.0Revenue, Q2 FY2026, three months to 2025-10-31$15.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure16.6Revenue, Q3 FY2026, three months to 2026-01-31$16.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure13.8Revenue, Q4 FY2026, three months to 2026-04-30$13.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure15.2Revenue, Q1 FY2027, three months to 2026-07-31$15.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Cost of revenue$m6.6Cost of revenue, Q2 FY2024, three months to 2023-10-31$6.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure7.8Cost of revenue, Q3 FY2024, three months to 2024-01-31$7.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure7.3Cost of revenue, Q4 FY2024, three months to 2024-04-30$7.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure7.1Cost of revenue, Q1 FY2025, three months to 2024-07-31$7.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure7.4Cost of revenue, Q2 FY2025, three months to 2024-10-31$7.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure6.6Cost of revenue, Q3 FY2025, three months to 2025-01-31$6.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure7.3Cost of revenue, Q4 FY2025, three months to 2025-04-30$7.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure8.0Cost of revenue, Q1 FY2026, three months to 2025-07-31$8.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure7.3Cost of revenue, Q2 FY2026, three months to 2025-10-31$7.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure8.8Cost of revenue, Q3 FY2026, three months to 2026-01-31$8.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure6.8Cost of revenue, Q4 FY2026, three months to 2026-04-30$6.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure7.5Cost of revenue, Q1 FY2027, three months to 2026-07-31$7.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Research and development$m2.5Research and development, Q2 FY2024, three months to 2023-10-31$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure2.2Research and development, Q3 FY2024, three months to 2024-01-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure2.1Research and development, Q4 FY2024, three months to 2024-04-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure1.5Research and development, Q1 FY2025, three months to 2024-07-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure1.7Research and development, Q2 FY2025, three months to 2024-10-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure1.7Research and development, Q3 FY2025, three months to 2025-01-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure2.0Research and development, Q4 FY2025, three months to 2025-04-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure2.1Research and development, Q1 FY2026, three months to 2025-07-31$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure2.6Research and development, Q2 FY2026, three months to 2025-10-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure2.3Research and development, Q3 FY2026, three months to 2026-01-31$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure2.1Research and development, Q4 FY2026, three months to 2026-04-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure2.3Research and development, Q1 FY2027, three months to 2026-07-31$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Operating income$m(2.0)Operating income, Q2 FY2024, three months to 2023-10-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure(2.6)Operating income, Q3 FY2024, three months to 2024-01-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure(0.3)Operating income, Q4 FY2024, three months to 2024-04-30−$271.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure1.3Operating income, Q1 FY2025, three months to 2024-07-31$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure0.7Operating income, Q2 FY2025, three months to 2024-10-31$732.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure4.5Operating income, Q3 FY2025, three months to 2025-01-31$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure(2.0)Operating income, Q4 FY2025, three months to 2025-04-30−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Operating income, Q1 FY2026, three months to 2025-07-31−$527.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure0.2Operating income, Q2 FY2026, three months to 2025-10-31$185.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure(0.3)Operating income, Q3 FY2026, three months to 2026-01-31−$276.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure(0.5)Operating income, Q4 FY2026, three months to 2026-04-30−$522.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure(0.4)Operating income, Q1 FY2027, three months to 2026-07-31−$409.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Income tax$m0.0Income tax, Q2 FY2024, three months to 2023-10-31$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-01-31$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure(0.1)Income tax, Q4 FY2024, three months to 2024-04-30−$81.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2024-07-31$21.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure0.0Income tax, Q2 FY2025, three months to 2024-10-31$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-01-31$23.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure(0.1)Income tax, Q4 FY2025, three months to 2025-04-30−$129.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2025-07-31$14.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure0.0Income tax, Q2 FY2026, three months to 2025-10-31$18.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure0.0Income tax, Q3 FY2026, three months to 2026-01-31$42.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure0.2Income tax, Q4 FY2026, three months to 2026-04-30$172.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2027, three months to 2026-07-31$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Net income$m(2.1)Net income, Q2 FY2024, three months to 2023-10-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure(2.5)Net income, Q3 FY2024, three months to 2024-01-31−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure(0.1)Net income, Q4 FY2024, three months to 2024-04-30−$109.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure1.3Net income, Q1 FY2025, three months to 2024-07-31$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure0.7Net income, Q2 FY2025, three months to 2024-10-31$728.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure4.5Net income, Q3 FY2025, three months to 2025-01-31$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure(1.8)Net income, Q4 FY2025, three months to 2025-04-30−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Net income, Q1 FY2026, three months to 2025-07-31−$466.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure0.3Net income, Q2 FY2026, three months to 2025-10-31$268.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure(0.3)Net income, Q3 FY2026, three months to 2026-01-31−$279.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure(0.7)Net income, Q4 FY2026, three months to 2026-04-30−$667.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure(0.4)Net income, Q1 FY2027, three months to 2026-07-31−$426.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Diluted EPS$ per share(0.15)Diluted EPS, Q2 FY2024, three months to 2023-10-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure(0.19)Diluted EPS, Q3 FY2024, three months to 2024-01-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figurenot reported0.09Diluted EPS, Q1 FY2025, three months to 2024-07-31$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure0.05Diluted EPS, Q2 FY2025, three months to 2024-10-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure0.31Diluted EPS, Q3 FY2025, three months to 2025-01-31$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2026, three months to 2025-07-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure0.02Diluted EPS, Q2 FY2026, three months to 2025-10-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure(0.02)Diluted EPS, Q3 FY2026, three months to 2026-01-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figurenot reportednot reported
Basic EPS$ per share(0.15)Basic EPS, Q2 FY2024, three months to 2023-10-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure(0.19)Basic EPS, Q3 FY2024, three months to 2024-01-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figurenot reported0.10Basic EPS, Q1 FY2025, three months to 2024-07-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure0.05Basic EPS, Q2 FY2025, three months to 2024-10-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure0.33Basic EPS, Q3 FY2025, three months to 2025-01-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figurenot reported(0.03)Basic EPS, Q1 FY2026, three months to 2025-07-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure0.02Basic EPS, Q2 FY2026, three months to 2025-10-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure(0.02)Basic EPS, Q3 FY2026, three months to 2026-01-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figurenot reported(0.03)Basic EPS, Q1 FY2027, three months to 2026-07-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure

Balance sheet

Cash and equivalents$4.4m, Q1 FY2027
Shareholders' equity$3.9m, Q1 FY2027
Champions Oncology, Inc., balance sheet, quarterly
Line itemUnitQ2 FY20242023-10-31Q3 FY20242024-01-31FY20242024-04-30Q1 FY20252024-07-31Q2 FY20252024-10-31Q3 FY20252025-01-31FY20252025-04-30Q1 FY20262025-07-31Q2 FY20262025-10-31Q3 FY20262026-01-31FY20262026-04-30Q1 FY20272026-07-31
Cash and equivalents$m5.5Cash and equivalents, Q2 FY2024, at 2023-10-31$5.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-12-13, accession 0001628280-23-041457.Report this figure4.5Cash and equivalents, Q3 FY2024, at 2024-01-31$4.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-03-15, accession 0001628280-24-011279.Report this figure2.6Cash and equivalents, FY2024, at 2024-04-30$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure2.9Cash and equivalents, Q1 FY2025, at 2024-07-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-09-13, accession 0001628280-24-040312.Report this figure2.8Cash and equivalents, Q2 FY2025, at 2024-10-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure3.2Cash and equivalents, Q3 FY2025, at 2025-01-31$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure9.8Cash and equivalents, FY2025, at 2025-04-30$9.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure10.3Cash and equivalents, Q1 FY2026, at 2025-07-31$10.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure8.5Cash and equivalents, Q2 FY2026, at 2025-10-31$8.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure7.1Cash and equivalents, Q3 FY2026, at 2026-01-31$7.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure4.9Cash and equivalents, FY2026, at 2026-04-30$4.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure4.4Cash and equivalents, Q1 FY2027, at 2026-07-31$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Current assets$m14.0Current assets, Q2 FY2024, at 2023-10-31$14.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-12-13, accession 0001628280-23-041457.Report this figure13.2Current assets, Q3 FY2024, at 2024-01-31$13.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-03-15, accession 0001628280-24-011279.Report this figure13.6Current assets, FY2024, at 2024-04-30$13.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-07-23, accession 0001628280-25-035765.Report this figure13.2Current assets, Q1 FY2025, at 2024-07-31$13.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-09-13, accession 0001628280-24-040312.Report this figure14.1Current assets, Q2 FY2025, at 2024-10-31$14.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure19.7Current assets, Q3 FY2025, at 2025-01-31$19.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure22.4Current assets, FY2025, at 2025-04-30$22.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-07-27, accession 0001628280-26-049834.Report this figure21.0Current assets, Q1 FY2026, at 2025-07-31$21.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure21.3Current assets, Q2 FY2026, at 2025-10-31$21.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure20.2Current assets, Q3 FY2026, at 2026-01-31$20.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure19.2Current assets, FY2026, at 2026-04-30$19.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure19.3Current assets, Q1 FY2027, at 2026-07-31$19.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Total assets$m28.3Total assets, Q2 FY2024, at 2023-10-31$28.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-12-13, accession 0001628280-23-041457.Report this figure26.8Total assets, Q3 FY2024, at 2024-01-31$26.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-03-15, accession 0001628280-24-011279.Report this figure26.1Total assets, FY2024, at 2024-04-30$26.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-07-23, accession 0001628280-25-035765.Report this figure24.9Total assets, Q1 FY2025, at 2024-07-31$24.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-09-13, accession 0001628280-24-040312.Report this figure25.2Total assets, Q2 FY2025, at 2024-10-31$25.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure30.6Total assets, Q3 FY2025, at 2025-01-31$30.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure32.3Total assets, FY2025, at 2025-04-30$32.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-07-27, accession 0001628280-26-049834.Report this figure30.5Total assets, Q1 FY2026, at 2025-07-31$30.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure30.2Total assets, Q2 FY2026, at 2025-10-31$30.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure28.4Total assets, Q3 FY2026, at 2026-01-31$28.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure27.0Total assets, FY2026, at 2026-04-30$27.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure33.3Total assets, Q1 FY2027, at 2026-07-31$33.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Current liabilities$m21.0Current liabilities, Q2 FY2024, at 2023-10-31$20.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-12-13, accession 0001628280-23-041457.Report this figure22.0Current liabilities, Q3 FY2024, at 2024-01-31$22.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-03-15, accession 0001628280-24-011279.Report this figure21.5Current liabilities, FY2024, at 2024-04-30$21.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-07-23, accession 0001628280-25-035765.Report this figure19.2Current liabilities, Q1 FY2025, at 2024-07-31$19.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-09-13, accession 0001628280-24-040312.Report this figure18.9Current liabilities, Q2 FY2025, at 2024-10-31$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure19.9Current liabilities, Q3 FY2025, at 2025-01-31$19.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure23.9Current liabilities, FY2025, at 2025-04-30$23.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-07-27, accession 0001628280-26-049834.Report this figure22.7Current liabilities, Q1 FY2026, at 2025-07-31$22.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure22.1Current liabilities, Q2 FY2026, at 2025-10-31$22.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure20.7Current liabilities, Q3 FY2026, at 2026-01-31$20.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure19.9Current liabilities, FY2026, at 2026-04-30$19.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure18.7Current liabilities, Q1 FY2027, at 2026-07-31$18.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Total liabilities$m28.2Total liabilities, Q2 FY2024, at 2023-10-31$28.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-12-13, accession 0001628280-23-041457.Report this figure28.8Total liabilities, Q3 FY2024, at 2024-01-31$28.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-03-15, accession 0001628280-24-011279.Report this figure28.0Total liabilities, FY2024, at 2024-04-30$28.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-07-23, accession 0001628280-25-035765.Report this figure25.3Total liabilities, Q1 FY2025, at 2024-07-31$25.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-09-13, accession 0001628280-24-040312.Report this figure24.6Total liabilities, Q2 FY2025, at 2024-10-31$24.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure25.2Total liabilities, Q3 FY2025, at 2025-01-31$25.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure28.6Total liabilities, FY2025, at 2025-04-30$28.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-07-27, accession 0001628280-26-049834.Report this figure27.0Total liabilities, Q1 FY2026, at 2025-07-31$27.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure25.9Total liabilities, Q2 FY2026, at 2025-10-31$25.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure24.1Total liabilities, Q3 FY2026, at 2026-01-31$24.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure22.9Total liabilities, FY2026, at 2026-04-30$22.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure28.8Total liabilities, Q1 FY2027, at 2026-07-31$28.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Shareholders' equity$m0.1Shareholders' equity, Q2 FY2024, at 2023-10-31$93.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure(2.1)Shareholders' equity, Q3 FY2024, at 2024-01-31−$2.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure(1.9)Shareholders' equity, FY2024, at 2024-04-30−$1.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-07-23, accession 0001628280-25-035765.Report this figure(0.3)Shareholders' equity, Q1 FY2025, at 2024-07-31−$332.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure0.7Shareholders' equity, Q2 FY2025, at 2024-10-31$681.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure5.5Shareholders' equity, Q3 FY2025, at 2025-01-31$5.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure3.8Shareholders' equity, FY2025, at 2025-04-30$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-07-27, accession 0001628280-26-049834.Report this figure3.5Shareholders' equity, Q1 FY2026, at 2025-07-31$3.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure4.2Shareholders' equity, Q2 FY2026, at 2025-10-31$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure4.3Shareholders' equity, Q3 FY2026, at 2026-01-31$4.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure3.9Shareholders' equity, FY2026, at 2026-04-30$3.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure3.9Shareholders' equity, Q1 FY2027, at 2026-07-31$3.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure

Cash flow

Operating cash flow−$492.0k, Q1 FY2027
Capital expenditure$55.0k, Q1 FY2027
Share repurchases$0, Q4 FY2025
Champions Oncology, Inc., cash flow, quarterly
Line itemUnitQ2 FY20242023-10-31Q3 FY20242024-01-31Q4 FY20242024-04-30Q1 FY20252024-07-31Q2 FY20252024-10-31Q3 FY20252025-01-31Q4 FY20252025-04-30Q1 FY20262025-07-31Q2 FY20262025-10-31Q3 FY20262026-01-31Q4 FY20262026-04-30Q1 FY20272026-07-31
Operating cash flow$k589Operating cash flow, Q2 FY2024, three months to 2023-10-31$589.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-12-16, accession 0001628280-24-051389. Derived: 6-month figure less the 3-month figure.Report this figure(919)Operating cash flow, Q3 FY2024, three months to 2024-01-31−$919.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-03-17, accession 0001628280-25-012941. Derived: 9-month figure less the 6-month figure.Report this figure(1,816)Operating cash flow, Q4 FY2024, three months to 2024-04-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure311Operating cash flow, Q1 FY2025, three months to 2024-07-31$311.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure(283)Operating cash flow, Q2 FY2025, three months to 2024-10-31−$283.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-15, accession 0001628280-25-057082. Derived: 6-month figure less the 3-month figure.Report this figure490Operating cash flow, Q3 FY2025, three months to 2025-01-31$490.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-12, accession 0001628280-26-017345. Derived: 9-month figure less the 6-month figure.Report this figure6,868Operating cash flow, Q4 FY2025, three months to 2025-04-30$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure600Operating cash flow, Q1 FY2026, three months to 2025-07-31$600.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure(1,735)Operating cash flow, Q2 FY2026, three months to 2025-10-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-15, accession 0001628280-25-057082. Derived: 6-month figure less the 3-month figure.Report this figure(1,339)Operating cash flow, Q3 FY2026, three months to 2026-01-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-12, accession 0001628280-26-017345. Derived: 9-month figure less the 6-month figure.Report this figure(1,998)Operating cash flow, Q4 FY2026, three months to 2026-04-30−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure(492)Operating cash flow, Q1 FY2027, three months to 2026-07-31−$492.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Capital expenditure$k79.0Capital expenditure, Q2 FY2024, three months to 2023-10-31$79.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-12-16, accession 0001628280-24-051389. Derived: 6-month figure less the 3-month figure.Report this figure92.0Capital expenditure, Q3 FY2024, three months to 2024-01-31$92.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-03-17, accession 0001628280-25-012941. Derived: 9-month figure less the 6-month figure.Report this figure(3.0)Capital expenditure, Q4 FY2024, three months to 2024-04-30−$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2024-07-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure94.0Capital expenditure, Q2 FY2025, three months to 2024-10-31$94.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-12-15, accession 0001628280-25-057082. Derived: 6-month figure less the 3-month figure.Report this figure42.0Capital expenditure, Q3 FY2025, three months to 2025-01-31$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-03-12, accession 0001628280-26-017345. Derived: 9-month figure less the 6-month figure.Report this figure253Capital expenditure, Q4 FY2025, three months to 2025-04-30$253.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure46.0Capital expenditure, Q1 FY2026, three months to 2025-07-31$46.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure242Capital expenditure, Q2 FY2026, three months to 2025-10-31$242.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-12-15, accession 0001628280-25-057082. Derived: 6-month figure less the 3-month figure.Report this figure37.0Capital expenditure, Q3 FY2026, three months to 2026-01-31$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-03-12, accession 0001628280-26-017345. Derived: 9-month figure less the 6-month figure.Report this figure239Capital expenditure, Q4 FY2026, three months to 2026-04-30$239.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-27, accession 0001628280-26-049834. Derived: 12-month figure less the 9-month figure.Report this figure55.0Capital expenditure, Q1 FY2027, three months to 2026-07-31$55.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure
Share repurchases$k32.0Share repurchases, Q2 FY2024, three months to 2023-10-31$32.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-12-16, accession 0001628280-24-051389. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-01-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-03-17, accession 0001628280-25-012941. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-04-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2024-07-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-09-13, accession 0001628280-24-040312.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2024-10-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-12-16, accession 0001628280-24-051389. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-01-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-03-17, accession 0001628280-25-012941. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-04-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-07-23, accession 0001628280-25-035765. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)13.89m, Q3 FY2026
Champions Oncology, Inc., shares, quarterly
Line itemUnitQ1 FY20232022-07-31Q2 FY20232022-10-31Q3 FY20232023-01-31Q1 FY20242023-07-31Q2 FY20242023-10-31Q3 FY20242024-01-31Q1 FY20252024-07-31Q2 FY20252024-10-31Q3 FY20252025-01-31Q1 FY20262025-07-31Q2 FY20262025-10-31Q3 FY20262026-01-31
Diluted shares (weighted)m shares13.5Diluted shares (weighted), Q1 FY2023, three months to 2022-07-3113,522,433 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-09-13, accession 0001628280-23-032212.Report this figure13.5Diluted shares (weighted), Q2 FY2023, three months to 2022-10-3113,528,643 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-12-13, accession 0001628280-23-041457.Report this figure13.6Diluted shares (weighted), Q3 FY2023, three months to 2023-01-3113,558,642 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-03-15, accession 0001628280-24-011279.Report this figure13.5Diluted shares (weighted), Q1 FY2024, three months to 2023-07-3113,506,782 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-09-13, accession 0001628280-24-040312.Report this figure13.5Diluted shares (weighted), Q2 FY2024, three months to 2023-10-3113,497,061 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-12-16, accession 0001628280-24-051389.Report this figure13.6Diluted shares (weighted), Q3 FY2024, three months to 2024-01-3113,593,758 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-03-17, accession 0001628280-25-012941.Report this figure14.0Diluted shares (weighted), Q1 FY2025, three months to 2024-07-3114,042,379 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure14.0Diluted shares (weighted), Q2 FY2025, three months to 2024-10-3114,016,953 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure14.4Diluted shares (weighted), Q3 FY2025, three months to 2025-01-3114,364,904 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure13.8Diluted shares (weighted), Q1 FY2026, three months to 2025-07-3113,788,414 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-09-15, accession 0000771856-25-000023.Report this figure14.5Diluted shares (weighted), Q2 FY2026, three months to 2025-10-3114,457,837 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-12-15, accession 0001628280-25-057082.Report this figure13.9Diluted shares (weighted), Q3 FY2026, three months to 2026-01-3113,886,797 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-03-12, accession 0001628280-26-017345.Report this figure

Shares outstanding: 13.92mShares outstanding, period not labelled, at 2026-09-0913,918,569 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-09-11, accession 0001628280-26-061519.Report this figure at Sep 9, 2026, from the cover of the 10-Q filed Sep 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. Listed shows no prices and gives no investment advice.